According to Jornaldebrasilia on January 20th, the Brazilian National Health Surveillance Agency (Anvisa) has canceled its planned visit to British American Tobacco (BAT) in London to avoid being misunderstood as reopening the discussion on e-cigarette authorization in Brazil.
This visit, originally scheduled from January 28th to 31st, includes two directors and two staff members.
Anvisa stated in a declaration: "Anvisa's regulatory process is guided by transparency and predictability, ensuring that its regulatory agenda is widely known by society." According to Anvisa, the cancellation of this visit was to avoid the public from misunderstanding the organization's goals in regulating tobacco products.
Currently, Congress is fiercely debating the possibility of lifting the ban on e-cigarettes in Brazil. Anvisa updated its regulations in April 2024 and decided to continue prohibiting these devices as a preventive measure until there is sufficient research proving their safety.
Anvisa reiterated that e-cigarette devices are banned in Brazil, and currently there is no new evidence sufficient to reopen discussion on the topic.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
